ClinConnect ClinConnect Logo
Search / Trial NCT06598618

Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Sep 12, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Iastm Met Iliotibial Band Patellofemoral Pain Syndrome

ClinConnect Summary

This clinical trial is studying two different treatment methods for people with patellofemoral pain syndrome, which is a common knee problem that causes pain in the front of the knee. The trial aims to compare the effects of Instrument Assisted Soft Tissue Mobilization (IASTM) and a technique called muscle energy on reducing tightness in a muscle band along the outside of the thigh. The hope is that one of these treatments will help relieve pain, improve movement, and enhance overall function for those affected.

To participate in this trial, individuals need to be between 18 and 35 years old and have been experiencing knee pain for at least three months. Eligible participants should feel pain in their knees during activities like climbing stairs, squatting, or sitting for long periods. They should also have specific signs of knee pain when tested by a healthcare professional. However, people with certain conditions, such as knee injuries or prior surgeries, will not be able to join the study. Participants can expect to receive one of the two treatments and will be monitored throughout the trial to see how it affects their knee pain and mobility.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Age between 18 and 35 years
  • Both Genders.
  • Anterior or retro patellar knee pain for at least the past 3 months.
  • Knee pain during at least 3 of the following activities: ascending/descending stairs, squatting, hopping/ running, and prolonged sitting.
  • Retro patellar pain in patellar grind test (positive clarke's sign).
  • A score of at least 3 on the visual analog scale (VAS).
  • Positive Ober's test.
  • Exclusion Criteria:
  • • Any meniscal or ligament tears of knee.
  • Knee osteoarthritis.
  • Any previous surgery of lower limb.
  • Patellar fracture or fracture of lower extremity.
  • Having received knee injections of corticosteroids or hyaluronic acid.
  • Osteoporosis of knee joint.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Rawalpindi, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

KINZA ANWAR, MS-OMPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported